Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD). The “hallmark feature” of COPD is a sustained reduction of expiratory airflow ...

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

Treatment with Nucala, an interleukin-5 antagonist monoclonal antibody, significantly reduced exacerbations leading to hospitalizations and emergency department visits. The Food and Drug ...

The COPD-HELP study enrolled 238 patients hospitalized with a severe COPD exacerbation and an eosinophil count of at least 300 cells/µL in the past year. 1 Participants were randomized to receive ...

The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P. Bhatt, MD, MSPH, of the University of Alabama at Birmingham ...

SAN FRANCISCO — The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater with dupilumab vs. placebo, according to findings ...

Diagnosing and treating COPD as early as possible leads to better outcomes. Now, doctors use a device called a spirometer to measure the volume of air a person breathes out. That helps them to ...